The unveiling of the Warburg effect and the inscribed innovative approach to a radical non toxic anticancer therapy by Crociani, Olivia et al.
Full Terms & Conditions of access and use can be found at
https://www.tandfonline.com/action/journalInformation?journalCode=kccy20
Cell Cycle
ISSN: 1538-4101 (Print) 1551-4005 (Online) Journal homepage: https://www.tandfonline.com/loi/kccy20
The unveiling of the Warburg effect and the
inscribed innovative approach to a radical non
toxic anticancer therapy
Olivia Crociani, Ilaria Marzi, Maria Grazia Cipolleschi, Antonella Mannini,
Massimo Contini & Massimo Olivotto
To cite this article: Olivia Crociani, Ilaria Marzi, Maria Grazia Cipolleschi, Antonella Mannini,
Massimo Contini & Massimo Olivotto (2018) The unveiling of the Warburg effect and the inscribed
innovative approach to a radical non toxic anticancer therapy , Cell Cycle, 17:3, 288-297, DOI:
10.1080/15384101.2017.1403679
To link to this article:  https://doi.org/10.1080/15384101.2017.1403679
© 2018 The Author(s). Published by Informa
UK Limited, trading as Taylor & Francis
Group
Published online: 19 Mar 2018.
Submit your article to this journal 
Article views: 572
View related articles 
View Crossmark data
PERSPECTIVE
The unveiling of the Warburg effect and the inscribed innovative approach to a radical
non toxic anticancer therapy
Olivia Crociani b#, Ilaria Marzi a#, Maria Grazia Cipolleschi a, Antonella Mannini b, Massimo Contini b and
Massimo Olivotto a
aDepartment Biomedical, Experimental and Clinical Sciences, University of Firenze, Viale Morgagni, 50–50134, Italy; bDepartment Experimental and
Clinical Medicine, University of Firenze, Viale Morgagni, 50–50134, Italy
ARTICLE HISTORY
Received 22 August 2017
Accepted 29 October 2017
ABSTRACT
The purpose of this research has been deciphering the Warburg paradox, the biochemical enigma
unsolved since 1923. We solved it by demonstrating that its specific character, i.e. the forced aerobic
lactate exportation, represents a crucial metabolic device to counteract the cytotoxic effect produced by
an excess of pyruvate at the connection of glycolysis with the Krebs cycle. This solution was verified by
exposing cancer cells of different histogenesis to pyruvate concentrations higher than the physiological
ones, after showing that these concentrations are totally innocuous when injected into mice. The
mechanism of the pyruvate cytotoxicity relies on the saturation of the respiratory chain, leading to a
negative shift of the cytosolic NADP/NADPH ratio and the consequent restriction of the purine synthesis
and the related cell apoptosis. The reducing equivalents generated by glycolysis and by cytosolic
metabolism compete each other for their disposal trough the respiratory chain; this makes it that the
cytotoxicity of pyruvate is inversely related to the mitochondrial number and efficiency of various cell
types. Thus, the cytotoxicity is high in anaplastic cancer stem cells, whose mitochondria are extremely few
and immature (cristae-poor); on the contrary, no inhibition is brought about in adult differentiated cells,
physiologically rich of mature mitochondria. All this generates the pyruvate anticancer selectivity, together








The modern oncology converges to the idea that the cancer stem
cells (CSCs) pool may be selected target to eradicate the neoplas-
tic disease [1]. This perspective highly incites investigations on
origin, fate and evolution of the cell populations confluent in the
neoplastic stem cell compartment. Innumerable studies are
aimed at finding aggressive treatments selective for the CSCs
rather than the stem cells normally living in differentiated tissues.
The limelight is nowadays occupied by the search of metabolic
features distinguishing normal from cancer stem compartments,
to be employed for selective anticancer treatments. Up to date,
the exhausting exploration of this field suggests that the unique
pathognonomic character sufficient to identify the neoplastic
malignant transformation is the so calledWarburg effect.
The aerobic glycolysis and the Warburg’s effect:
Dfinition and oncological implications
So long as 1923, Otto Warburg [2] distinguished two glycolytic
pathways on the basis of the final exportation of lactate in the
cellular environment. He demonstrated that one pathway pro-
duces lactate only in the absence of O2 (the anaerobic glycoly-
sis), whereas the other produces lactate despite the presence of
O2 (the aerobic glycolysis); the anaerobic glycolysis was brought
about by any type of cells, whereas the aerobic glycolysis was
carried out only by embryonic tissues and by whatsoever ana-
plastic cancer. This finding is nowadays the basis, evidencing
lactate in aerobic tissues by the PET methodology, that is
regarded as a clinical clue of malignancy development [3].
Since the first description, the aerobic glycolysis appeared a
paradoxical energetic waste (the Warburg effect, or paradox).
Indeed, the arrest of the aerobic glucose metabolism at the
pyruvate level, with lactate exportation, reduces the energetic
yield to 2 ATP per glucose against the 36 obtainable from the
whole molecule.
The Warburg effect and the connected metabolic crossways
have been object of intensive investigations in our laboratory
throughout the last forty years, initially employing the ascites
hepatoma AH130 [4–7]. This highly anaplastic tumor was gen-
erated by treating Wistar rats with the carcinogen o-aminoazo-
toluene and has been widely used as in vivo model of
experimental cancer [8,9]. After serial transplantations in rat
peritoneal cavity, this tumor became composed of isolated
spheroidal cells, fed by the ascites fluid extruded from the peri-
toneal vessels. Recently, we showed that these cells display a
Pluripotent-like cell phenotype, which expresses fundamental
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Embryonic Transcription Factors (ETFs), such as Nanog, Klf4
and c-Myc [10]: these factors operate a transcriptional circuitry
that controls the cell cycle as a function of pO2. At advances
stages of tumor development in vivo, the intraperitoneal pO2 is
near zero, making the bulk survive as an anaerobic population
arrested in G0/G1.
Experiments performed with this model provided the fol-
lowing fundamental information reported below. Anaplastic
cancer possess a huge capacity of aerobic glycolysis, converting
glucose to lactate at percentages increasing with glucose exter-
nal concentrations. This is shown in Table 1, which reports the
glycolytic balance of AH130 hepatoma cells at their recruitment
into the S phase from the anaerobic resting state. This synchro-
nized cell entering into the S phase is measured by the rate of
radioactive 14C-thymidine incorporation into DNA.
When incubated in 15 mM glucose, this G1/S transition
consumed 11 mmol/106 cells in 18 hours, exporting 18 mmol of
lactate: this means that 80% of imported glucose was converted
to lactate. Incubating the same cells in 0.5 mM glucose continu-
ously renewed, the sugar uptake fell down to 1 mmol (95%
decrease), and lactate exportation decreased to 0.7 mmol (97%
decrease). Thus, cancer can uptake enormous amounts of glu-
cose, exporting lactate proportionally to the sugar uptake.
Noteworthy, cell recruitment into S phase turned out to be
even higher in 0.5 mM in environmental glucose than in
15 mM.
On the whole, the amount of glucose necessary for the opti-
mal cell growth is far less than that the cell can uptake, pro-
vided that the amount exceeding the optimum is totally
converted to lactate. With 10 mM glucose, a concentration fre-
quently used in cell culture, this conversion produces an energy
waste that can be calculated as (34 £ 11 = ) 374 ATP.
Table 2 shows that cell recruitment into the mitotic cycle is
abolished in anaerobiosis (nitrogen incubation), as well as by
blocking the mitochondrial respiratory chain with a specific
inhibitor of the cytochrome-oxidase, antimycin A [7,11]; on
the other hand, no inhibition of cell recruitment was produced
blocking the mitochondrial ATP generation, uncoupling the
oxidative phosphorylation with 2,4 dinitrophenol (DNP). In
addition to that, the total intracellular ATP content turned out
to be the same with either antimycin A or DNP treatment.
Equally, the same was the rate of an energy-dependent process,
such as protein synthesis estimated by 3H – Lysine incorpo-
ration into proteins.
These data appear even more relevant considering the rate
of O2 consumption (DQ O2/min) in the presence of various
inhibitors. The block of this parameter with nitrogen incuba-
tion produced an 80% inhibition of cell recruitment, whereas
no significant effect was obtained by uncoupling the oxidative
phosphorylation with DNP, despite the doubling of O2 con-
sumption brought about by this inhibitor [7,11]. These data
demonstrate that the energy for cancer growth is entirely sup-
plied by respiration in that it affords the electron transport to
oxygen through the respiratory chain, without significant con-
tribution by the oxidative phosphorylation. These bioenergetic
features reflect precisely those of the cristae-poor mitochondria
of stem cells adapted to the physiological hypoxia [12]. This
suggested that the metabolic network controlling the cancer
stem recruitment resides in the intimate mechanisms of this
adaptation.
The genesis and maintenance of stem cells in the
physiological hypoxia: The hypoxic niche
Recent studies showed that gradients of pO2 below 1% is the
selective environment for stem cells, in line with the concept of
physiological hypoxia, introduced to describe the naturally low
oxygen tension (pO2 > 2) experienced by cells during the nor-
mal development [13]. Oxygen concentrations range from 1%
to 5% in the uterine environment [14], and in the mouse
embryo cells in low oxygen (<2%) are widespread until mater-
nal and foetal blood interfaces around midgestion [13,15]. The
Table 1. The tumor cell recruitment into the S phase and the aerobic glycolysis as
function of glucose external concentration. Data refer to H130 Hepatoma, adapted
















15 11.18 17.78 79.5 87 100
10 9 12.5 69 100 100
5 8.9 12.4 69 95 100
3 7 8.9 63.5 90 100
2 5 6 60 90 90
1 2.5 2 40 85 85
0.5 1 0.7 35 100 80
0.2 0.2 ¡1.8^ 0 74 100
0 0 – – 20 27
Table 2. Effects of various treatments on recruitment of cell H130 Hepatoma into S phase. Data refer to time interval 0/18hrs as mmoles or
matoms/min/106 viable cells. Various are means § standard error, in parenthesis number of experiments. n.d. not determined; n.s. not significant;
 = P<0.05;  = P<0.01. Data were adapted from 11.
Control N2 Antimicin A DNP
14C-Thym. 10,678§877 770§173 (3) 2,127§656 (6) 10,161§355 (2)
(R) (20) ¡93% ¡80% ¡5%
  n.s.




ΔO2/min 1.99§0.12 (3) – 0.35§0.1 (3) 4.07§0.84 (3)
¡82% +105%
 




physiological hypoxia transcriptionally activates genes that are
involved in energy metabolism, promoting tolerance to hypoxia
by decreasing the cellular requirement and increasing the sup-
ply of oxygen [13,16,17].
In a series of papers [18–22], it has been postulated that such
physiological hypoxia is localized also in restricted areas of
adult differentiated tissues, allowing stem cells survival in the
resting state. This localization was indeed sustained by the
demonstration that bone marrow microareas were hypoxic rel-
ative to other tissues and that this localization was a crucial fac-
tor in the determination of stem cell fate and maintenance.
These studies introduced the concept of Hypoxic Niche [19], in
keeping with the observation that hemopoietic stem cells
(HSCs) are confined to regions of the bone marrow blood
where the blood pO2 is lower than in other tissues and is equiv-
alent to that of blood in jugular vein. These cells are in strict
contact with several stromal and progenitor cells, physically
residing between the HSCs and cells close to blood vessels. This
arrangement represents a selective locus apt to preserve the cel-
lular at pO2 below 1%, as compared to that of 6% in sinusoidal
cavity. Actually, HSCs are selectively maintained in these
niches, whereas the fast cycling early hemopoietic progenitors,
with limited capacity of cell renewal, reside in areas far from
the vasculature [23].
The major advantage of residing in hypoxic niches is that
stem cells can maintain indefinitely a slow-cycling proliferation
rate, avoiding the oxidative stress associated with well oxygen-
ated tissues [19].
The CSCs evolution and reprogramming
CSCs represent the oncological equivalent of the physiological
stem cell compartment. This view derives from a widely
accepted model [24], which proposes a cell hierarchical organi-
zation of stem cells originating from Embryonic Stem Cells
(ESCs). The latter are physiologically generated from the
inner mass of the embryo in the hypoxic gastrula environment
(pO2  2%), and are endowed with unlimited self renewal,
together with the capacity of generating all types of tissues
(Pluripotent Stem Cells = PSCs). These properties are main-
tained until the cells remain in hypoxic environments, express-
ing the ETFs, which operate the silencing of the differentiation
genes. The occurrence of ESCs-like expressing ETFs in adult
differentiated tissues, or in anaplastic tumors, represents an
anomaly menacing an irreversible perturbation of growth.
Thus, the identification and elimination of reprogrammed stem
like cells in adult tissues is a crucial objective to pursue the
eradication of the neoplastic disease.
In this light, we decided to focus our interest in anaplastic
tumors expressing fundamental ETFs such as Nanog, Klf4,
cMyc and Sox2. [10,25–27].
The ectopic presence of ESCs raises the question of how
these cells get into such anomalous locations. Nowadays, two
speculative explanations have been proposed; a) ESCs migrate
from gastrula to cancer, surviving in some ischemic areas of the
tumor bulk; b) ESCs can be de novo generated in the context of
adult tissues in the course of intense genetic and epigenetic
alterations leading to the chromatin plasticity, which trans-
forms differentiated tissues into immature cell populations.
This plasticity is produced by the convergence of the two fol-
lowing processes:
a) NEOPLASTIC PROGRESSION. This term was introduced by 28
to synthesise the fact that “Tumors change from bad to
worse”. It consists of a series of gradual genetic and epi-
genetic mutations involving distinct, independently
matched characters, which progressively drive the ana-
plastic dedifferentiation of cancer [10,11,25].
b) CELL REPROGRAMMING. This is the process inducing differ-
entiated cells to invert their developmental potency
down to obtain the pluripotent state typical of the
induced PSCs (iPSCs) [27]. This state is strongly facili-
tated by the neoplastic progression.
Mitochondrial reprogramming
A crucial information obtained in the course of the iPSCs gen-
eration is their glycolytic-oriented metabolism, in the absence
of substantial energetic contribution by a rudimental cristae
poor mitochondrial apparatus [12]. Noteworthy, the differenti-
ation promotes an intense mitochondrial biogenesis to form
networks of elongated and cristae rich mitochondria entitled to
support a competent oxidative metabolism [12]. Moreover, the
conversion of differentiated cells to iPSCs induces a profound
mitochondrial regression from elongated and cristae-rich ele-
ments to small spherical and cristae-poor remnant structures.
This, together with the up regulation of the glycolytic enzymes
[12,27]. These findings explain the fact that, in the dedifferenti-
ated cancer cells, the respiration does not generate ATP, in
keeping with the data reported in Table 2. This metabolic trim
is typical of hypoxia adaptation, accounting up to 90% failure
of chemotherapeutic treatments [28].
The unveiling of Warburg paradox
Information so far led us to approach the solution of the War-
burg paradox conceiving that its specific character, i.e. the
forced aerobic exportation of lactate (recall Table 1), represents
a crucial metabolic device to counteract some cytotoxic effect
brought about by an excess of pyruvate at the connection of
glycolysis with the Krebs cycle. This hypothesis was verified
exposing cancer cells to pyruvate at concentrations much
higher than the physiological ones, after showing that these
concentrations are totally innocuous when injected i.p. into
mice (see below).
The anticancer cytotoxic activity of pyruvate
As shown in Fig. 1, Pyruvate determined an I.C.50 growth inhi-
bition between 7.8 and 12.5 mM (reaching 100% inhibition
around 20 mM) in different highly anaplastic tumors of differ-
ent phenotypes, including AH130 Hepatoma, A375, M26C and
SSM2C melanoma cell lines and K562 leukemia cell line. Sub-
stantially unaffected resulted bone marrow cells (BMC) and
normal clonogenic lymphocytes.
The pyruvate cancer cytotoxicity was then explored in vivo,
injecting an anaplastic melanoma cell line (SSM2c, 25) in nude
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mice (nu/nu), (104 cells/mouse). Pyruvate was injected daily
intraperitoneal (ip), at dosages sufficient to make all the organ-
ism contain the same concentration of pyruvate used in vitro
(20 mM) and after checking that a fivefold higher dose
(100 mM) resulted totally innocuous in control mice, through-
out one year. The anticancer activity of pyruvate was definitely
confirmed by i): the delay of metastatic nodules development
in pyruvate treated mice as compared to controls; ii) the mas-
sive apoptosis characterizing the nodules developed in the
pyruvate treated mice. As shown Fig. 2A, the melanoma injec-
tion, followed throughout three months from the day of cancer
cell inoculation, produced metastatic nodules developing with
the two kinetics, representing, respectively, the nodules
developed in controls (ctr, black kinetics), and the nodules
developed in mice daily treated with 5.5 mg of pyruvate (pyr,
red kinetics).
Fig. 2B, column I, shows the vigorous melanoma cell popu-
lation developing in the absence of pyruvate in control mice,
stained with hematoxilin, panel (a) and negative for the apopto-
tic specific TUNEL reaction panel (d). Note the lack of evidence
of any flogistic infiltrate.
Fig. 2B column II and III shows the progressive cell apopto-
sis developing in the metastatic nodules, characterizing pyru-
vate treated mice. Column II (panel b) shows the initial
evidence of necrosis and its apoptotic nature, revealed by
TUNEL positive cells (panel e). The massive evolution of these
two types of cell death is clearly shown in column III, panels
(c) and (f).
The explanation of this Figure requires recalling some fea-
tures of apoptosis. This is a complex, ATP-dependent process,
due to multiple DNA mutations, which manifest only after
latencies since the application of the initiating event [29]. We
showed that the impairment of the respiratory chain by pyru-
vate or antimycin A leads to a severe restriction of purine pool,
without affecting the pyrimidine pool [26]. Since DNA synthe-
sis and turn-over are tightly coupled with the balance among
the various deoxynucleotides, alteration of this balance produ-
ces high ratios of mis-incorporation of this precursors into
DNA, and hence genetic mutations [30]. Up to a certain limit,
these mutations can be repaired by an efficient p53; on the con-
trary, they trigger cell apoptosis when p53 is deleted or altered
as usually happens in anaplastic tumors. This explains why the
pyruvate cytotoxicity produces the apoptotic type of cell death.
[30].
Altogether, this sequence explains the apoptotic delay with
respect to the trigger stimulus and mirrors the apoptotic effect
produced by pyruvate. Note the total absence of signs of inflam-
mation (leukocytes, hyperhaemia), that always accompany the
instantaneous cell death produced by highly toxic insults.
Figure 1. The sensitivity of various cancer and normal stem cell populations to the
cytotoxic activity of pyruvate. Values are expressed as IC50 of cell growth in the
presence of varying concentrations of the substrate. AH130: Hepatoma; A375,
M26C and SSM2C melanoma cell lines; K562 leukemia cell line; BMC: bone marrow
cells; Lymphoc.: normal clonogenic lymphocytes. Values were determined after
18 hrs treatment, seeding 105 viable cells/well. Adapted from 25.
Figure 2. In vivo efficacy of a long-term pyruvate treatment. A) Time course of tumor masses growth in control (ctr) and daily treated mice (pyr). Tumor volumes were
measured by caliper, following the formula (Width Length 0,54). B) Hematoxylin and eosin staining (panels a-c); Terminal dUTP Nick End-Labeling (TUNEL) assay (R&D
systems) (panels d-f). Column I panel (a-d): picture of early necrosis, where single apoptotic cells are present; column II panel (b-e): picture of late apoptosis associated to
an initial necrotic process; column III, panel c-f: massive cellular death to extensive apoptotic and necrotic processes.
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On the whole, data in Fig. 2 are consistent with a temporal
sequence like that represented by the kinetics reported in panel
A.Data so far indicate that pyruvate fulfils the requisites we
conceived proper to act as the cytotoxic agent, active at the con-
nection between glycolysis and Krebs cycle. In other words, the
elimination of pyruvate as lactate indeed represents an indis-
pensable metabolic device to allow an unrestricted growth of
cells with an immature mitochondrial apparatus. In anaplastic
cancer stem cells, this in turn allows the use of the combined
energy supply by the glycolytic pathway, without saturating
the respiratory chain. This device provides the decisive
selective advantage inscribed in the Warburg paradox. As sim-
ple as that.
The metabolic network underlying the pyruvate
cytotoxicity
As a first step to explore the general impact of pyruvate, we
compared its cytotoxicity with the other fundamental sub-
strates of the Krebs cycle.
As shown in Fig. 3A, this effect is strictly proportional to the
rate of oxygen consumption (DQO2) measured as described in
4 and 32, while pyruvate turned out to be by far the most active.
This is in keeping with the fact that pyruvate is the only glyco-
lytic substrate directly connecting glycolysis to the Krebs cycle
before entering any prior metabolization.
This study was continued by recalling the data reported in
Table 2, showing that the pyruvate inhibition of tumor growth
depends on the rudimental mitochondrial apparatus of cancer
cells, which support the electron flux to oxygen, without oper-
ating the oxidative phosphorylation. It ensues that the pyruvate
impairs some mitochondrial function other than the ATP gen-
eration. This function can only be the regulation of the cellular
redox state expressed by the cytosolic NADP/NADPH ratio,
according to the reaction
H Substrateþ NADPÐ substrate þ NADPH (1)
The reoxidation of this NADPH is brought about through the
shuttles systems, which transport the reducing equivalents (H)
across the mitochondrial external membrane.
This mechanism operates in one crucial step of the synthesis
of the purine ring summarized in the following equation:
Methylene-tetrahydrofolate ðCH2FH4Þ þ NADP
ÐMethenyl-tetraydrodrofolate ðCH FH4Þ þ NADPH (2)
catalyzed by the methylenedehyrogenase, where CH-FH4 repre-
sents the group 2 of the adenine ring (see also Fig. 5). This reac-
tion accounts for the dependence of purine synthesis on the
NADP/NADPH ratio and, hence, on reoxidation of the reduc-
ing equivalent through the respiratory chain. All this produces
that the inhibition or saturation of this chain restricts the
purine pools with the arrest of the cell cycle.
Such involvement of purine synthesis in the pyruvate cyto-
toxicity was confirmed by showing that this inhibition is 100%
removed by adding preformed purines (50% by guanine), while
is totally unaffected by adding the pyrimidine base cytosine
and uracil (Fig. 3B). The dependence of the purine pools on the
respiratory chain was explored by testing its response to anti-
mycin A. As shown in Fig. 3C, this inhibitor determined a 70%
restriction of the Adenine pool, totally removed by folate (F).
Moreover, antimycin A produced a 90% reduction of the
NADP/NADPH ratio (Fig. 3D).
The definite evidence that NADP/NADPH ratio gears the
purine synthesis was obtained by modifying this ratio accord-
ing to the classical reaction:
Fþ NADPHÐ FH4 þNADP (3)
catalyzed by the Dihydrofolic reductase (DHIFR), selectively
inhibited by the antineoplastic Metotrexate (MTX).
As predicted by this equation, the addition of high doses of
FH4 produces an increment of NADPH and the equivalent
decrease of NADP, with the consequent reduction of the
NADP/NADPH ratio, and hence the arrest of cell cycle. A sub-
stantial reduction of the NADP/NADPH ratio is also produced
by adding 5 mM glutamine (gln), as an effect of glutaminolysis
pathway.
The addition of the reduced form of FH4 strongly dimin-
ishes the cell content of NADP and enhanced NADPH, while,
the addition of F tends to diminish NADPH and enhances
NADP.
A strong increment of NADPH is also produced by the anti-
neoplastic agent Metotrexate (MTX), which is the selective
inhibitor of the enzyme catalyzing the above reaction, Dihydro-
folic reductase (DHFR).
The NADP/NADPH ratios measured in all the conditions
experimented in this study, expressed of percentages of control,
are condensed in Fig. 4A. When these data are compared with
the corresponding rates of cancer cell recruitment into the
cycle, R, (as in Fig. 3B), it emerged that this recruitment is a lin-
ear function of the NADP/NADPH ratio (Fig. 4B).
This complex metabolic network is outlined in the Fig. 5,
where it is summarized the metabolic network described above.
The ultimate target of pyruvate: The cancer stem cell
As an experimental insight into this direction, we explored the
pyruvate inhibition of the stem self renewal in highly anaplastic
metastatic melanoma cell lines in vitro and in vivo.
The in vitro experiments were carried out using the human
melanoma cell line A375 [25]. In the in vitro procedures per-
formed on these highly metastatic melanoma, Pyruvate drasti-
cally abolished sphere formation at the same extent as the
conventional chemotherapic drug methotrexate (Fig. 6 panel B
and C, respectively) [25]. As shown in Fig. 6 panel D, the addi-
tion of folate do not significantly alter the sphere formation
with respect to the control (panel A), while FH4 (FH4, panel E)
abolished the sphere generation, at the same extent as pyruvate
(panel B) and MTX (panel C).
The sphere abolition was accompanied by an extensive apo-
ptotic cell death, as demonstrated in Fig. 6F by the strong posi-
tivity to the cleaved caspase 3, reported in the A375 melanoma
cells upon the addition of pyruvate or FH4.
These data demonstrate that the physiological factors, such
as FH4 and pyruvate, exert a strong cytotoxic effect on
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melanoma cells, similar to that of MTX, drastically interfering
with stem cell renewal. Moreover, it is worth noting that, even
in absence of these compounds, their inhibitory effect is evident
also in secondary and tertiary spheres derived from the dissoci-
ation of the cells previously treated with FH4 and pyruvate,
respectively [25]. These results indicate that the cytotoxicity of
the tested physiological agents not only reduces the melanoma
stem cell generation, but it is also memorized, influencing the
self-renewal ability by the further sphere generation after the
agent removal.
This “memorization process” was confirmed by the in vivo
experiments reported in Fig. 7 [25]. Briefly, A375 melanoma
cells with high stemness potential, obtained by dissociation
from primary spheres, was split in 2 cultures, which were incu-
bated for 1 week either in the presence of 20 mM pyruvate or
PBS. At the end of this incubation, 104 viable pyruvate or PBS-
Figure 3. The role of cellular redox-state in the cytotoxic activity of physiological agents: the involvement of purine and folate metabolism. (A) The inhibition of cell
recruitment into the S phase of AH130 cells by the Krebs cycle substrates, as a function of the corresponding rate of O2 consumption. O2 consumption (DQO2) is
expressed as ml of O2 per mg of dry weight per hour. Ketog, a-ketoglutarate; Succ, Succinate; Mal, Malate; Fum, Fumarate; Citr, Citrate; OxalAc, Oxalacetate; Pyr, pyruvate.
All substrates are used at [10 mM]. R = rate of 14C-Thymidine incorporation into DNA per 90 min per 106 viable cells at 18 hours of incubation in air. Values are expressed
as % of control. (B) Effects of purine and pyrimidines on pyruvate inhibition of AH130 cell recruitment into the S phase. Abbreviations: pyr, pyruvate; ade, adenine; guan,
guanine; thym, thymidine; cyt, cytosine; urac, uracile. Pyruvate was added at 10 mM; all bases are used at 0.5 mM. All additions were performed at time 0. Values are
means § SEM of 3 separate experiments. (C) antimycin A (ant.A) inhibition of adenine pool and its removal by folate in AH130 cells. Values are expressed as nmol/5 £
107 viable cells at 18 hours of incubation in air and are means § SEM of 6 separate experiments. Ant.A (6 £ 10¡6M), F (100 mmol), gln, glutamine (5 mM).were added at
t = 0. (D) The effects of various treatments on the intracellular NADP/NADPH ratio in AH130 cells. NADP and NADPH were estimated by HPLC technique and are expressed
as percentage of control at t = 18 hours of incubation in air, and are means§ SEM of 5 separate experiments. P < 0.02; P < 0.001. Adapted from 25.
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treated cells were injected subcutaneously into nude mice to
test their tumorigenicity. As shown in Fig. 7A, pyruvate pre-
treatment caused an inhibition of tumor growth, determining a
remarkable reduction of metastasis number and size (Fig. 7B).
Histological examination of pyruvate-treated nodules shown a
mass of apoptotic cells, in contrast with the metastatic nodules
developed in PBS injected mice.
The milestones of the Radical anticancer therapy
inscribed in the Warburg effect
On the whole, this study produced the following milestones to
orient a radical therapy of anaplastic cancer:
1) to be successful, such therapy must be selectively tar-
geted to the stem compartment, which is resistant to
chemo and radiochemical treatments.
2) The stem compartment is segregated in and, adapted to,
hypoxic districts (the hypoxic niches), where they sur-
vive in a resting state. This adaptation implies a remnant
mitochondrial apparatus, whose respiratory chain is sub-
stantially devoid of the cristae supporting the electron
transport and the correlated oxidative phosphorylation.
3) As a consequence of point 2, stem cells surviving in hyp-
oxic niches derive their energetic supply exclusively by
the metabolic process that Warburg named anaerobic
glycolysis, in which pyruvate is actively converted to lac-
tate by the lactate dehydrogenase (LDH), in the reaction
Pyrþ NADHÐLactþ NAD (4)
This reaction is essential to dispose of the reducing equivalents
(H+) produced by the anaerobic glycolysis, restoring the NAD
necessary in the upstream equation.
Glyceradehyde-3Pþ NADþ P
Ð 3phosphoglyceroilphosphateþ NADHþHþ (5)
This metabolic sequence maintains the high self renewal and
pluripotence of stemness, and changes as soon as the stem cells
exit from the niche and meet incremented oxygen tension.
Such evolution is centered on an intense neobiogenesis of cris-
tae rich-mitochondria, leading to the progressive transition
from the anaerobic glycolytic to the oxidative respiratory
metabolism [12]. Such transition allows the continuous reoxi-
dation of the cytosolic NADP/NADPH ratio that controls the
NADP dependent dehydrogenations required for the metabolic
trigger of the mitotic cycle. In the initial phase, the high energy
required must be supplied by oxidative phosphorylation in
addition to glycolysis, so that the respective reducing equiva-
lents compete for a still restricted mitochondrial respiratory
capacity. So far, glucose is catabolized through the ancestral
anaerobic glycolysis as much as the pyruvate commitment to
the Krebs cycle can be maintained below the saturation of the
mitochondrial respiratory chain at the expense of the oxidative
phosphorylation (see below).
All this generate an overall metabolic trim where glucose
utilization is in part stopped at the pyruvate/lactate conver-
sion, despite the aerobic environment. This competition
underlines the aerobic glycolysis, at a rate inversely propor-
tional to the maturated mitochondrial respiration. In
embryonic tissues as well as anaplastic cancer, this equip-
ment is poor, implying the necessity of this metabolic
competition.
In the adult differentiated cells, the mitochondrial apparatus
is normally so well developed to allow the total glucose oxida-
tion through the Krebs cycle and the respiratory chain, avoid-
ing any lactate production through the aerobic glycolysis.
The definition of Cancer cytotoxic physiological
factors
Data so far lead to conclude that pyruvate is the prototype of
physiogical agents, including also FH4 and Glutamine, that can
be regarded as a category of Cancer Cytotoxic Physiological
Figure 4. The central role of the NADP/NADPH ratio in the control of ascites cell recruitment into S. A. Effects of various factors on the NADP/NADPH ratio. F clearly shows
an opposite effect respect to all the others substrates, resulting much higher even than the control. The stimulating effect of F removes almost completely the antimycin
inhibition. The ratio was determined at 18 hours of incubation in air. Additions were performed at t = 0. Contr: control; Mtx. methotrexate; Pyr: pyruvate; Ant: antimycin;
FH4 tetrahydrofolate.; glu: glutamine; F: folate; B. The correlation between AH130 cell recruitment into S and the NADP/NADPH ratio under various conditions. Correlation
index, R = 0.98. P < 0.05; P < 0.02; P < 0.001. Adapted from 25.
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Factors (CCPFs), whose potential use in therapy deserves to be
tested as to their clinical use. Indeed, all these factors are cur-
rently used in therapy at dosages that, in the case of pyruvate
proved innocuous at dosages hundreds times higher than those
used in this study to eliminate the cancer stem compartment.
Since 1990s, pyruvate is employed as diet integrator at 5g/day
for man or woman on a liquid diet [31,32].
Clinical perspectives
CCPFs emerged from this study as anticancer factors targeted
to the hypoxia selected cancer stem cells migrating out of
their hypoxic niches, before they accomplish the intense mito-
chondriogenesis, that characterizes this stage. Two peculiari-
ties make them represent an ideal agents to approach a
radical therapy of the neoplastic disease; a) they are highly
effective on stem compartments, the more the higher the
tumor immaturity; b) they are totally innocuous to adult dif-
ferentiated cell; c) their current commercial and extremely
cheap availability.
On these bases, the CCPFs should be regarded as suitable
to attempt a radical anticancer therapy, abolishing the
cancer renewal with avoiding toxic and ineffectual
chemotherapies.
Figure 5. The metabolic network which regulates the cell cycle activation at the O2 dependent G1/S transition and its modification by pyruvate addition. The core of the
network is the cellular redox-state expressed by the cytosolic NADP/NADPH ratio. This ratio (A) regulates the transfer of reducing equivalents (H) from the methylene-tet-
rahydrofolate (CH2-FH4) to methenyl-trahydrofolate (CH-FH4), a crucial NADP-dependent reaction generating NADPH. This is a limiting step of the synthesis of purine
ring (B), required for the amplification of purine pools indispensable for the G1/S transition. A fundamental role in the regulation of the NADP/NADPH ratio is played by
folate, whose reduction to FH4 by the dehydrofolic reductase (DHFR) generates NADP (A). The addition of an excess of FH4 impairs the DHFR activity, leading to an incre-
ment of NADPH, with the consequent reductive shift of the NADP/NADPH ratio and the inhibition of the G1/S transition. Consistently, FH4 mimics the effects of MTX, a
powerful inhibitor of DHFR (A), incrementing the NADPH levels and inhibiting cell recruitment into S. Whatever the mechanism incrementing the cytosolic NADPH, includ-
ing an excess of glutamine through the glutaminolytic pathway (A), has an inhibitory effect, unless the NADPH is removed through the shuttle mechanisms, which dis-
charge the cytosolic reducing equivalents onto the mitochondrial respiratory chain. The frame above is regulated by the size and shape of the mitochondrial apparatus,
see the oval sketches (C) in the Figure. Actually, the respiratory chain, which is the mitochondrial core, deeply differs in adult differentiated cells as compared to stem cell
and cancer undifferentiated cells; the adult cells normally contain a high number of differentiated cristae-rich mitochondria (dashed black line), whereas stem cancer cells
contain very few cristae-poor mithocondria (red line). This difference implies that the two cell types can exploit two different amount of disposal of reducing equivalents
(H) produced both by the glycolytic pathway as well as by the metabolic oxidative reduction carried out in the cytosol. In fact, these sources compete each other for the
respiratory chain with the following consequences. Up to the point that no one of the two sources saturate the respiratory chain, glycolysis will be performed down to
the final oxidation of glucose down to CO2 and H2O, without arresting glucose metabolism at the level of the pyruvate exportation through the lactate conversion. This is
the reason why adult differentiated cell do not produce lactate but in anaerobiosis, or upon inhibition of respiratory chain (e.g. by antimycin A). This is what Warburg
called the anaerobic glycolysis, which is the pathway that each cell must activate in severe hypoxia. On the other hand, whenever in aerobic conditions, the cytosolic sour-
ces tend to saturate the respiratory chain (e.g. in the presence of an excess of pyruvate) the cell brings about the total oxidation of glucose without lactate conversion,
proportionally to the unsaturation of respiratory chain. Under this conditions, the cell will produce lactate despite the presence of O2, which is what Warburg defined aer-
obic glycolysis, the enigma remains so far the Warburg paradox, with the inscribed anticancer therapeutic suggestion explore in this study. The extreme pyruvate antican-
cer selectivity derives from the easy saturation of the respiratory chain of the immature cancer mitochondria, as compare to the vast number of the mature mithocondria
of adult differentiated cells. Indeed the saturation of differentiated cells is not obtainable at concentrations thousand time higher than the cancer cytotoxic ones. Updated
from 25.
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Figure 6. The cytotoxic effects of physiological agents on melanoma stem cells. Effects of various treatments on sphere formation derived from A375 melanoma cells (A–
E). (F) Percentage of Cleaved caspase 3-positive cells after treatment with cytotoxic physiological agents. ctr: control; pyr: pyruvate; Mtx: methotrexate; F: folate; FH4: tetra-
hydrofolate. F = 100 mM, FH4 = 100 mM, pyr = 20 mM, MTX = 10¡6M. (F) Updated from 25.
Figure 7. Pyruvate pretreatment of viable A375 melanoma cells strongly reduces the tumor development in vivo. (A) The inhibitory effect of pyruvate pre-treatment on
melanoma growth in vivo. Scale bar = 10 mm. (B) Quantification of tumor volume. Values represent the averages of tumors developed at various times and expressed as
mean § SEM (n = 12, each). (C) Histological sections of tumors derived from PBS- (upper pictures) and pyruvate-treated melanoma stem cells (lower pictures) counter-
stained with Hematoxylin and Eosin (H&E). Scale bar left pictures = 100 mm, right pictures = 25 mm. Adapted from 25.
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